New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
10:07 EDTARIA, REPH, RSPP, NMM, HOLI, CSTM, CAB, BMRN, ATW, ATHL, AEO, ALE, SNSSOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: ARIAD (ARIA) coverage transitioned with a Neutral at UBS... Allete (ALE) initiated with a Neutral at JPMorgan... American Eagle (AEO) initiated with a Fair Value at CRT Capital... Athlon Energy (ATHL) initiated with a Buy at Mizuho... Atwood Oceanics (ATW) initiated with a Hold at Deutsche Bank... BioMarin (BMRN) coverage transitioned with a Buy at UBS... Cabela's (CAB) initiated with a Neutral at Goldman... Constellium (CSTM) initiated with a Buy at Sterne Agee... Hollysys Automation (HOLI) initiated with a Buy at Goldman... Navios Maritime Partners (NMM) initiated with a Buy at Jefferies... RSP Permian (RSPP) initiated with a Buy at Mizuho... Recro Pharma (REPH) initiated with a Buy at Aegis... Sunesis (SNSS) initiated with a Buy at UBS.
News For ARIA;ALE;AEO;ATHL;ATW;BMRN;CAB;CSTM;HOLI;NMM;RSPP;REPH;SNSS From The Last 14 Days
Check below for free stories on ARIA;ALE;AEO;ATHL;ATW;BMRN;CAB;CSTM;HOLI;NMM;RSPP;REPH;SNSS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 21, 2014
10:02 EDTRSPPOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:04 EDTHOLIHollysys Automation awarded $8.28M contract by Shenyang - Dandong rail line
Subscribe for More Information
07:32 EDTRSPPRSP Permian upgraded to Buy from Accumulate at KLR Group
KLR Group upgraded RSP Permian to Buy citing the company's production growth and "superior" capital yield. The firm raised its price target for shares to $42 from $34.
July 17, 2014
09:04 EDTRSPPRSP Permian raises 2014 production outlook to 11,500-12,000 Boe/d
Raises 2014 CapEx to approximately $425M. Expects to fund it through a combination of cash and cash equivalents, operating cash flow, borrowings under RSP's revolving credit facility, and potential debt capital markets transactions.
09:04 EDTRSPPRSP Permian reports Q2 average daily production up 15% to 10,714 Boe/d
Subscribe for More Information
07:24 EDTCSTMConstellium price target raised to $36 from $31 at JPMorgan
Subscribe for More Information
July 16, 2014
14:30 EDTATWAtwood Oceanics mentioned as potential takeover target by The Deal
Subscribe for More Information
13:51 EDTALEAllete unit reaches settlement agreement with EPA
Minnesota Power, a utility division of ALLETE, has reached a settlement agreement with the Environmental Protection Agency and the Minnesota Pollution Control Agency that resolves alleged violations of the New Source Review provisions of the Clean Air Act. The agreement does not include any admission of wrongdoing on the part of the company. The settlement agreement covers Minnesota Power’s Boswell, Laskin, Taconite Harbor and Rapids Energy Centers and includes more stringent emissions limits than in current air permits at all affected units, and the option of refueling, retrofits and retirements at some units. It also includes the addition of 200 megawatts of wind energy. Minnesota Power will also spend $4.2M over the next five years in conservation and clean energy projects benefitting local communities, which could potentially include a forest restoration project, an electric car charging station in northeastern Minnesota and a 1 megawatt solar installation on Fond du Lac Band of Lake Superior Chippewa property. Under the terms of the settlement, the company will also pay a $1.4M civil penalty. In Q2, ALLETE recorded an after-tax expense of $2.5M, or $0.06 per share, to reflect a liability associated with the conservation and clean energy projects. Due to its non-recurring nature, the expense will be excluded from 2014 earnings guidance.
July 15, 2014
10:56 EDTBMRNFed calls small cap social media, biotech valuations 'stretched'
The Board of Governors of the Federal Reserve in its Monetary Policy Report dated today said valuation metrics in "some sectors" appear substantially stretched, "particularly those for smaller firms in the social media and biotechnology industries, despite a notable downturn in equity prices for such firms early in the year." A later part in the document reads, "Equity valuations of smaller firms as well as social media and biotechnology firms appear to be stretched, with ratios of prices to forward earnings remaining high relative to historical norms." The specific targeting of sectors by the Fed seems to be having an impact on stocks in the social media and biotech spaces. Shares of Yelp (YELP) are down over 5% to $67.51, while Twitter (TWTR) and Facebook (FB) are each down 2%. Celgene (CELG) and Amgen (AMGN) are leading the biotech space lower with pullbacks of greater than 1%.
10:00 EDTATWOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:41 EDTATWAtwood Oceanics upgraded to Market Perform from Underperform at BMO Capital
BMO upgraded the offshore drillers to Market Perform from Underperform citing valuation, reduced expectations, and a slow resumption in activity. Price target raised to $50 from $45.
July 14, 2014
07:37 EDTARIAARIAD announces continuation of Iclusig review under Article 20 procedure
ARIAD Pharmaceuticals announced that the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency has provided the company with a request for limited additional information regarding Iclusig as part of its ongoing review under the Article 20 referral procedure. The PRAC has requested further information regarding proposed dose modifications after achievement of a response and patient monitoring and details concerning a risk management plan. Following ARIAD’s response and input from the agency’s Scientific Advisory Group, the company expects that the PRAC will complete its review and make final recommendations to the Committee for Medicinal Products for Human Use at its meeting in October. As we finalize our recommendations on dose modifications of Iclusig and response monitoring of patients, we will work closely with the European regulatory agency and its expert advisors so that CML patients and their treating physicians have the best guidance available supporting the appropriate use of Iclusig,” said Timothy P. Clackson, Ph.D., president of research and development and chief scientific officer at ARIAD. In March ARIAD submitted responses to initial questions outlined by the PRAC as part of the Article 20 process, which was initiated in December of last year, and responses to a second set of questions were submitted to the PRAC in June.
July 10, 2014
13:25 EDTARIAARIAD mentioned positively by Stansberry Research
Subscribe for More Information
11:18 EDTAEOZumiez rallies after raising second quarter outlook
Subscribe for More Information
July 9, 2014
07:07 EDTSNSSSunesis announces EMA acceptance of PIP for Qinprezo
Subscribe for More Information
July 8, 2014
11:53 EDTARIAOptions with increasing implied volatility
Options with increasing implied volatility: VJET XONE ARIA FTNT STX DAL PSEC SAN AMJ

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use